GREM1 and cancer: Furthermore, secreted bone Morphogenetic protein antagonist, Gremlin1 (GREM1), can inhibit the osteogenic transformation of adipocytes, and some scholars believe that the expression of GREM1 can be a marker of activated myofibroblasts in cancer matrix or scar tissue [74].